Cerebrospinal fluid τ and β-amyloid(I-42) in dementia disorders

被引：47
|
作者：
Vanmechelen, E
Vanderstichele, H
Hulstaert, F
Andreasen, N
Minthon, L
Winblad, B
Davidsson, P
Blennow, K
机构：
[1] Innogenet NV, B-9052 Ghent, Belgium
[2] Pitea River Valley Hosp, Dept Rehabil, Pitea, Sweden
[3] Malmo Univ Hosp, Neuropsychiat Clin, Dept Clin Neurosci, Malmo, Sweden
[4] Karolinska Inst, Huddinge Univ Hosp, Geriatr Med Sect, Dept Clin Neurosci & Family Med, S-10521 Stockholm, Sweden
[5] Univ Gothenburg, Unit Neurochem, Dept Clin Neurosci, S-41320 Gothenburg, Sweden
来源：
MECHANISMS OF AGEING AND DEVELOPMENT | 2001年 / 122卷 / 16期
关键词：
cerebrospinal fluid; iota; beta-amyloid; Alzheimer's disease; dementia; diagnosis;
D O I：
10.1016/S0047-6374(01)00304-9
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The reliability of cerebrospinal fluid (CSF)-tau and CSF-beta -amyloid assays for diagnosis of Alzheimer's disease and other dementing disorders such as frontotemporal dementia (FTD), dementia with Lewy bodies (DLB) and Creutzfeldt-Jakob disease (CJD) is reviewed. CSF assessment of the two proteins is useful in early diagnosis of AD and to differentiate it from FTD and DLB. Extremely high CSF-tau levels can discriminate CJD from AD. (C) 2001 Elsevier Science Ireland Ltd, All rights reserved.
引用
收藏
页码：2005 / 2011
页数：7
相关论文
共 50 条
  • [41] Cerebrospinal Fluid Biomarkers in Dementia Patients with Cerebral Amyloid Angiopathy
    Yan-feng Li
    Fang-fang Ge
    Yong Zhang
    Hui You
    Zhen-xin Zhang
    ChineseMedicalSciencesJournal, 2015, 30 (03) : 170 - 173
  • [42] Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy
    Banerjee, Gargi
    Ambler, Gareth
    Keshavan, Ashvini
    Paterson, Ross W.
    Foiani, Martha S.
    Toombs, Jamie
    Heslegrave, Amanda
    Dickson, John C.
    Fraioli, Francesco
    Groves, Ashley M.
    Lunn, Michael P.
    Fox, Nick C.
    Zetterberg, Henrik
    Schott, Jonathan M.
    Werring, David J.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1189 - 1201
  • [43] Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
    Giacomo Stroffolini
    Giulia Guastamacchia
    Sabrina Audagnotto
    Cristiana Atzori
    Mattia Trunfio
    Marco Nigra
    Alessandro Di Stefano
    Giovanni Di Perri
    Andrea Calcagno
    BMC Neurology, 21
  • [44] Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group
    Shoji, M
    Matsubara, E
    Murakami, T
    Manabe, Y
    Abe, K
    Kanai, M
    Ikeda, M
    Tomidokoro, Y
    Shizuka, M
    Watanabe, M
    Amari, M
    Ishiguro, K
    Kawarabayashi, T
    Harigaya, Y
    Okamoto, K
    Nishimura, T
    Nakamura, Y
    Takeda, M
    Urakami, K
    Adachi, Y
    Nakashima, K
    Arai, H
    Sasaki, H
    Kanemaru, K
    Yamanouchi, H
    Yoshida, Y
    Ichise, K
    Tanaka, K
    Hamamoto, M
    Yamamoto, H
    Matsubayashi, T
    Yoshida, H
    Toji, H
    Nakamura, S
    Hirai, S
    NEUROBIOLOGY OF AGING, 2002, 23 (03) : 363 - 370
  • [45] Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
    Tamaoka, A
    Sawamura, N
    Fukushima, T
    Shoji, S
    Matsubara, E
    Shoji, M
    Hirai, S
    Furiya, Y
    Endoh, R
    Mori, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 148 (01) : 41 - 45
  • [46] Cerebrospinal fluid β-amyloid and dynabridging in Alzheimer's disease drug development
    Ereshefsky, Larry
    Jhee, Stanford
    Yen, Mark
    Moran, Samira
    Pretorius, Sybrand
    Adams, James
    BIOMARKERS IN MEDICINE, 2009, 3 (06) : 711 - 721
  • [47] Cerebrospinal fluid tau and amyloid β42 protein in patients with myotonic dystrophy type 1
    Winblad, S.
    Mansson, J. E.
    Blennow, K.
    Jensen, C.
    Samuelsson, L.
    Lindberg, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (09) : 947 - 952
  • [48] Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia
    He, Qiang
    Wang, Wenjing
    Xiong, Yang
    Tao, Chuanyuan
    Ma, Lu
    You, Chao
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 100 (02) : 603 - 611
  • [49] Cerebrospinal fluid biomarkers in neurodegenerative disorders
    Robey, Thalia T.
    Panegyres, Peter K.
    FUTURE NEUROLOGY, 2019, 14 (01)
  • [50] Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
    Vanderstichele, H
    Van Kerschaver, E
    Hesse, C
    Davidsson, P
    Buyse, MA
    Andreasen, N
    Minthon, L
    Wallin, A
    Blennow, K
    Vanmechelen, E
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (04): : 245 - 258
12345